Serveur d'exploration Stress et Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Biological warfare, bioterrorism, and biocrime

Identifieur interne : 000826 ( Pmc/Checkpoint ); précédent : 000825; suivant : 000827

Biological warfare, bioterrorism, and biocrime

Auteurs : H. J. Jansen ; F. J. Breeveld ; C. Stijnis ; M. P. Grobusch

Source :

RBID : PMC:7129974

Abstract

Abstract

Biological weapons achieve their intended target effects through the infectivity of disease‐causing infectious agents. The ability to use biological agents in warfare is prohibited by the Biological and Toxin Weapon Convention. Bioterrorism is defined as the deliberate release of viruses, bacteria or other agents used to cause illness or death in people, but also in animals or plants. It is aimed at creating casualties, terror, societal disruption, or economic loss, inspired by ideological, religious or political beliefs. The success of bioterroristic attempts is defined by the measure of societal disruption and panic, and not necessarily by the sheer number of casualties. Thus, making only a few individuals ill by the use of crude methods may be sufficient, as long as it creates the impact that is aimed for. The assessment of bioterrorism threats and motives have been described before. Biocrime implies the use of a biological agent to kill or make ill a single individual or small group of individuals, motivated by revenge or the desire for monetary gain by extortion, rather than by political, ideological, religious or other beliefs. The likelihood of a successful bioterrorist attack is not very large, given the technical difficulties and constraints. However, even if the number of casualties is likely to be limited, the impact of a bioterrorist attack can still be high. Measures aimed at enhancing diagnostic and therapeutic capabilities and capacities alongside training and education will improve the ability of society to combat ‘regular’ infectious diseases outbreaks, as well as mitigating the effects of bioterrorist attacks.


Url:
DOI: 10.1111/1469-0691.12699
PubMed: 24890710
PubMed Central: 7129974


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

PMC:7129974

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Biological warfare, bioterrorism, and biocrime</title>
<author>
<name sortKey="Jansen, H J" sort="Jansen, H J" uniqKey="Jansen H" first="H. J." last="Jansen">H. J. Jansen</name>
<affiliation>
<nlm:aff id="clm12699-aff-0001"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Breeveld, F J" sort="Breeveld, F J" uniqKey="Breeveld F" first="F. J." last="Breeveld">F. J. Breeveld</name>
<affiliation>
<nlm:aff id="clm12699-aff-0002"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Stijnis, C" sort="Stijnis, C" uniqKey="Stijnis C" first="C." last="Stijnis">C. Stijnis</name>
<affiliation>
<nlm:aff id="clm12699-aff-0001"></nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="clm12699-aff-0002"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Grobusch, M P" sort="Grobusch, M P" uniqKey="Grobusch M" first="M. P." last="Grobusch">M. P. Grobusch</name>
<affiliation>
<nlm:aff id="clm12699-aff-0002"></nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">24890710</idno>
<idno type="pmc">7129974</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129974</idno>
<idno type="RBID">PMC:7129974</idno>
<idno type="doi">10.1111/1469-0691.12699</idno>
<date when="2014">2014</date>
<idno type="wicri:Area/Pmc/Corpus">000888</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000888</idno>
<idno type="wicri:Area/Pmc/Curation">000888</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000888</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000826</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000826</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Biological warfare, bioterrorism, and biocrime</title>
<author>
<name sortKey="Jansen, H J" sort="Jansen, H J" uniqKey="Jansen H" first="H. J." last="Jansen">H. J. Jansen</name>
<affiliation>
<nlm:aff id="clm12699-aff-0001"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Breeveld, F J" sort="Breeveld, F J" uniqKey="Breeveld F" first="F. J." last="Breeveld">F. J. Breeveld</name>
<affiliation>
<nlm:aff id="clm12699-aff-0002"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Stijnis, C" sort="Stijnis, C" uniqKey="Stijnis C" first="C." last="Stijnis">C. Stijnis</name>
<affiliation>
<nlm:aff id="clm12699-aff-0001"></nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="clm12699-aff-0002"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Grobusch, M P" sort="Grobusch, M P" uniqKey="Grobusch M" first="M. P." last="Grobusch">M. P. Grobusch</name>
<affiliation>
<nlm:aff id="clm12699-aff-0002"></nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Clinical Microbiology and Infection</title>
<idno type="ISSN">1198-743X</idno>
<idno type="eISSN">1469-0691</idno>
<imprint>
<date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<title>Abstract</title>
<p>Biological weapons achieve their intended target effects through the infectivity of disease‐causing infectious agents. The ability to use biological agents in warfare is prohibited by the
<styled-content style="fixed-case" toggle="no">B</styled-content>
iological and
<styled-content style="fixed-case" toggle="no">T</styled-content>
oxin
<styled-content style="fixed-case" toggle="no">W</styled-content>
eapon
<styled-content style="fixed-case" toggle="no">C</styled-content>
onvention. Bioterrorism is defined as the deliberate release of viruses, bacteria or other agents used to cause illness or death in people, but also in animals or plants. It is aimed at creating casualties, terror, societal disruption, or economic loss, inspired by ideological, religious or political beliefs. The success of bioterroristic attempts is defined by the measure of societal disruption and panic, and not necessarily by the sheer number of casualties. Thus, making only a few individuals ill by the use of crude methods may be sufficient, as long as it creates the impact that is aimed for. The assessment of bioterrorism threats and motives have been described before. Biocrime implies the use of a biological agent to kill or make ill a single individual or small group of individuals, motivated by revenge or the desire for monetary gain by extortion, rather than by political, ideological, religious or other beliefs. The likelihood of a successful bioterrorist attack is not very large, given the technical difficulties and constraints. However, even if the number of casualties is likely to be limited, the impact of a bioterrorist attack can still be high. Measures aimed at enhancing diagnostic and therapeutic capabilities and capacities alongside training and education will improve the ability of society to combat ‘regular’ infectious diseases outbreaks, as well as mitigating the effects of bioterrorist attacks.</p>
</div>
</front>
<back>
<div1 type="bibliography">
<listBibl>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Kelly, Pw" uniqKey="Kelly P">PW Kelly</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Dembek, Zf" uniqKey="Dembek Z">ZF Dembek</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Leitenberg, M" uniqKey="Leitenberg M">M Leitenberg</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Morse, Sa" uniqKey="Morse S">SA Morse</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Fong, Iw" uniqKey="Fong I">IW Fong</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Dembek, Zf" uniqKey="Dembek Z">ZF Dembek</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<pmc article-type="review-article">
<pmc-dir>properties open_access</pmc-dir>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Clin Microbiol Infect</journal-id>
<journal-id journal-id-type="iso-abbrev">Clin. Microbiol. Infect</journal-id>
<journal-id journal-id-type="doi">10.1111/(ISSN)1469-0691</journal-id>
<journal-id journal-id-type="publisher-id">CLM</journal-id>
<journal-title-group>
<journal-title>Clinical Microbiology and Infection</journal-title>
</journal-title-group>
<issn pub-type="ppub">1198-743X</issn>
<issn pub-type="epub">1469-0691</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">24890710</article-id>
<article-id pub-id-type="pmc">7129974</article-id>
<article-id pub-id-type="doi">10.1111/1469-0691.12699</article-id>
<article-id pub-id-type="publisher-id">CLM12699</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Review</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Themed Section</subject>
<subj-group subj-group-type="heading">
<subject>Reviews</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Biological warfare, bioterrorism, and biocrime</article-title>
<alt-title alt-title-type="left-running-head">Jansen
<italic>et al</italic>
.</alt-title>
</title-group>
<contrib-group>
<contrib id="clm12699-cr-0001" contrib-type="author">
<name>
<surname>Jansen</surname>
<given-names>H. J.</given-names>
</name>
<xref ref-type="aff" rid="clm12699-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib id="clm12699-cr-0002" contrib-type="author">
<name>
<surname>Breeveld</surname>
<given-names>F. J.</given-names>
</name>
<xref ref-type="aff" rid="clm12699-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib id="clm12699-cr-0003" contrib-type="author">
<name>
<surname>Stijnis</surname>
<given-names>C.</given-names>
</name>
<xref ref-type="aff" rid="clm12699-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="clm12699-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib id="clm12699-cr-0004" contrib-type="author" corresp="yes">
<name>
<surname>Grobusch</surname>
<given-names>M. P.</given-names>
</name>
<xref ref-type="aff" rid="clm12699-aff-0002">
<sup>2</sup>
</xref>
</contrib>
</contrib-group>
<aff id="clm12699-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Expertise Centre Force Health Protection</named-content>
<institution>Ministry of Defence</institution>
<city>Doorn</city>
<country country="NL">The Netherlands</country>
</aff>
<aff id="clm12699-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Centre of Tropical Medicine and Travel Medicine</named-content>
<named-content content-type="organisation-division">Academic Medical Centre</named-content>
<institution>University of Amsterdam</institution>
<city>Amsterdam</city>
<country country="NL">the Netherlands</country>
</aff>
<author-notes>
<corresp id="correspondenceTo">
<label>*</label>
<bold>Corresponding author:</bold>
M. P. Grobusch, Centre of Tropical Medicine and Travel Medicine, Academic Medical Centre, University of Amsterdam, PO Box 22700, Meibergdreef 9, 1100 DE Amsterdam, the Netherlands
<break></break>
<bold>E‐mail:</bold>
<email>m.p.grobusch@amc.uva.nl</email>
<break></break>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>16</day>
<month>7</month>
<year>2014</year>
</pub-date>
<pub-date pub-type="ppub">
<month>6</month>
<year>2014</year>
</pub-date>
<volume>20</volume>
<issue>6</issue>
<issue-id pub-id-type="doi">10.1111/clm.2014.20.issue-6</issue-id>
<fpage>488</fpage>
<lpage>496</lpage>
<history>
<date date-type="received">
<day>28</day>
<month>4</month>
<year>2014</year>
</date>
<date date-type="rev-recd">
<day>24</day>
<month>5</month>
<year>2014</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>5</month>
<year>2014</year>
</date>
</history>
<permissions>
<pmc-comment> Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectious Diseases </pmc-comment>
<copyright-statement content-type="article-copyright">© 2014 The Authors Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectious Diseases</copyright-statement>
<license>
<license-p>This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:CLM-20-488.pdf"></self-uri>
<abstract id="clm12699-abs-0001">
<title>Abstract</title>
<p>Biological weapons achieve their intended target effects through the infectivity of disease‐causing infectious agents. The ability to use biological agents in warfare is prohibited by the
<styled-content style="fixed-case" toggle="no">B</styled-content>
iological and
<styled-content style="fixed-case" toggle="no">T</styled-content>
oxin
<styled-content style="fixed-case" toggle="no">W</styled-content>
eapon
<styled-content style="fixed-case" toggle="no">C</styled-content>
onvention. Bioterrorism is defined as the deliberate release of viruses, bacteria or other agents used to cause illness or death in people, but also in animals or plants. It is aimed at creating casualties, terror, societal disruption, or economic loss, inspired by ideological, religious or political beliefs. The success of bioterroristic attempts is defined by the measure of societal disruption and panic, and not necessarily by the sheer number of casualties. Thus, making only a few individuals ill by the use of crude methods may be sufficient, as long as it creates the impact that is aimed for. The assessment of bioterrorism threats and motives have been described before. Biocrime implies the use of a biological agent to kill or make ill a single individual or small group of individuals, motivated by revenge or the desire for monetary gain by extortion, rather than by political, ideological, religious or other beliefs. The likelihood of a successful bioterrorist attack is not very large, given the technical difficulties and constraints. However, even if the number of casualties is likely to be limited, the impact of a bioterrorist attack can still be high. Measures aimed at enhancing diagnostic and therapeutic capabilities and capacities alongside training and education will improve the ability of society to combat ‘regular’ infectious diseases outbreaks, as well as mitigating the effects of bioterrorist attacks.</p>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="clm12699-kwd-0001">Biocrime</kwd>
<kwd id="clm12699-kwd-0002">biological agents</kwd>
<kwd id="clm12699-kwd-0003">biological warfare</kwd>
<kwd id="clm12699-kwd-0004">bioterror</kwd>
<kwd id="clm12699-kwd-0005">bioterrorism</kwd>
<kwd id="clm12699-kwd-0006">bioweapons</kwd>
</kwd-group>
<counts>
<page-count count="9"></page-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>June 2014</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.0 mode:remove_FC converted:15.04.2020</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation publication-type="journal" id="clm12699-cit-1001">
<source xml:lang="en">Clin Microbiol Infect</source>
<year>2014</year>
;
<volume>20</volume>
:
<fpage>488</fpage>
<lpage>496</lpage>
<pub-id pub-id-type="pmid">24890710</pub-id>
</mixed-citation>
</p>
</notes>
</front>
</pmc>
<affiliations>
<list></list>
<tree>
<noCountry>
<name sortKey="Breeveld, F J" sort="Breeveld, F J" uniqKey="Breeveld F" first="F. J." last="Breeveld">F. J. Breeveld</name>
<name sortKey="Grobusch, M P" sort="Grobusch, M P" uniqKey="Grobusch M" first="M. P." last="Grobusch">M. P. Grobusch</name>
<name sortKey="Jansen, H J" sort="Jansen, H J" uniqKey="Jansen H" first="H. J." last="Jansen">H. J. Jansen</name>
<name sortKey="Stijnis, C" sort="Stijnis, C" uniqKey="Stijnis C" first="C." last="Stijnis">C. Stijnis</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Pmc/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000826 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd -nk 000826 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    StressCovidV1
   |flux=    Pmc
   |étape=   Checkpoint
   |type=    RBID
   |clé=     PMC:7129974
   |texte=   Biological warfare, bioterrorism, and biocrime
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/RBID.i   -Sk "pubmed:24890710" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a StressCovidV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed May 6 16:44:09 2020. Site generation: Sun Mar 28 08:26:57 2021